Workflow
Biomerica Reports First Quarter Fiscal 2025 Financial Results
BMRABiomerica(BMRA) GlobeNewswire News Room·2024-10-16 13:00

Total Revenue Increases 6% Over Same Period Last Year Cost-Saving Measures Now Implemented, Expected to Reduce Annual Expenses by 16% to 23%, Representing $1.0 to $1.4 Million Reduction Biomerica's At-Home PSA Screening Test Receives Saudi Food and Drug Authority (SFDA) Approval for Early Detection of Prostate Cancer IRVINE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the "Company") a global provider of advanced medical diagnostic and therapeutic products today reported financ ...